[ 5/9 (Wed) ]
KPAC 2018 (Korea Pharma Associations Conference)



Representative Info. Hyun Hee Leem, +82-2-6263-2058, hyunhee.leem@mci-group.kr
* You could participate this session without additional registration.
Time Session Title
13 : 00 ~ 14 : 00 Registration
14 : 00 ~ 14 : 10 Opening Remarks
KPBMA / KRPIA
14 : 10 ~ 14 : 25 Congratulatory Remarks
Minister of MOHW / Minister of MFDS
14 : 25 ~ 14 : 30 Photo Time
14 : 30 ~ 15 : 10 Keynote Speech
Philip Tagari, VP of Research, AMGEN
Panel Discussion
15 : 10 ~ 16 : 20 Session 1: Future of Oncology Biomarkers and How Open Innovation Works
Kiyoshi Hashigami, Head of Medical & Development for Japan, Korea and Taiwan, BMS
Byoung Chul Cho, Professor, Div. of Medical Oncology, Severance Hospital
Rosa Heejung Kim, Sr. Manager. IMED Biotech, AstraZeneca
Harry Hunwoo Shin, Director, BD&Licensing, MSD
16 : 40 ~ 17 : 50 Session 2: Implement ‘Quick Win Fast Fail Strategy’ for New Drug R&D
Birgit Reitmaier, Head of Access to Innovation APAC, Merck
Takao Honda , Sr. Manager, External Innovation, Eli Lilly Japan
Su Jin Ahn, Director of DMPK of Yuhan R&D Institute, Yuhan
Kouichi Akahane, Head of Oncology Function of R&D Div, Daiichi Sankyo